Refractory Graves' Disease Successfully Cured by Adjunctive Cholestyramine and Subsequent Total Thyroidectomy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Refractory Graves' Disease Successfully Cured by Adjunctive Cholestyramine and Subsequent Total Thyroidectomy

Published:2015 Issue:4 Volume:30 Page:620
ISSN:2093-596X
Container-title:Endocrinology and Metabolism
language:en
Short-container-title:Endocrinol Metab

Author:

Yang Yeoree¹,Hwang Seawon¹,Kim Minji¹,Lim Yejee¹,Kim Min-Hee¹,Lee Sohee²,Lim Dong-Jun¹,Kang Moo-Il¹,Cha Bong-Yun¹

Affiliation:

1. Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

2. Department of Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

Publisher

Korean Endocrine Society

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://synapse.koreamed.org/pdf/10.3803/EnM.2015.30.4.620

Reference17 articles.

1. The Diagnosis and Management of Hyperthyroidism in Korea: Consensus Report of the Korean Thyroid Association

2. Graves' Disease

3. Perioperative management of the thyrotoxic patient

4. A Hyperthyroid Patient with Graves' Disease Who Was Strongly Resistant to Methimazole: Investigation on Possible Mechanisms of the Resistance.

5. Dramatic Response to Cholestyramine in a Patient with Graves' Disease Resistant to Conventional Therapy

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Refractory Graves’ Disease in an Adolescent Successfully Treated With Cholestyramine and Subsequent Thyroidectomy;Cureus;2024-08-15

2. Enhanced predictive validity of integrative models for refractory hyperthyroidism considering baseline and early therapy characteristics: a prospective cohort study;Journal of Translational Medicine;2024-03-29

3. Carbimazole-Resistant Grave’s Thyrotoxicosis is a Diagnostic and Therapeutic Dilemma, Case Report with Literature Review;International Medical Case Reports Journal;2023-11

4. Management of refractory hyperthyroidism;L'Endocrinologo;2023-03-07

5. Non-thionamide antithyroid drug options in Graves’ hyperthyroidism;Expert Review of Endocrinology & Metabolism;2023-01-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3